BTG To Pay Up To $475M For Emphysema Treatment Maker
U.K. health care company BTG plc on Thursday said it would pay up to $475 million to acquire interventional pulmonology company PneumRX Inc., seeking to expand its own pulmonology business with...To view the full article, register now.
Already a subscriber? Click here to view full article